triple-negative breast cancer cell lines: LM2, Hs578T, MDA-MB-231 (human), 4T1, AT3 (mice)tumors from four triple-negative breast cancer trials treated with anti-PD-1 therapy (n = 109). Here, PDCD1 is linked to triple-negative breast carcinoma.